Advertisement

Organisation › Details
Thuja Capital (Group)
Thuja Capital Management (Thuja) is a dedicated life sciences venture capital firm with its office in Utrecht, The Netherlands. Thuja's team currently consists of 8 professionals (scaling to 10, of which 6 hold a PhD). Thuja has been active as an early stage life sciences investor since 2008. Since then, it has operated several funds totaling in excess of EUR 125M under management. Since then, Thuja has been involved mostly as of the start, with various successful ventures, amongst which Argenx (market cap 16.5 Bn USD), Okapi Biosciences, NightBalance and MILabs. For the active portfolio we refer to our website. To date, Thuja invested in 25 life sciences companies. Thuja is a signatory to the United Nations Principles for Responsible Investment. Besides financial objectives, Thuja selects investments that will positively affect the health and well-being of patients. *
![]() |
Start | 2010-09-20 existent |
![]() |
Industry | venture capital |
Industry 2 | LIFE SCIENCES | |
![]() |
Region | Utrecht |
Country | Netherlands | |
Street | 40 Yalelaan Utrecht Science Park, Alexandernumangebouw | |
City | 3584 CM Utrecht | |
Tel | +31-30-253-9898 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for �About Section�: Thuja Capital Management. (12/21/21). "Press Release: Thuja Announces the Final Close of Thuja Capital Healthcare Fund III at EUR 76M (USD 86M)". Utrecht. | ||
Record changed: 2021-12-23 |
Advertisement
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
More documents for Thuja Capital (Group)
- [1] Thuja Capital Management. (12/21/21). "Press Release: Thuja Announces the Final Close of Thuja Capital Healthcare Fund III at EUR 76M (USD 86M)". Utrecht....
- [2] Pan Cancer T B.V.. (10/28/21). "Press Release: Pan Cancer T Extends Seed Financing Round with Additional Funding from Existing Shareholders and New Investor Thuja Capital". Rotterdam....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top